About Atomwise
Atomwise is a company based in San Francisco (United States) founded in 2012 by Izhar Wallach.. Atomwise has raised $218.64 million across 8 funding rounds from investors including Tencent, Baidu and Khosla Ventures. The company has 70 employees as of December 31, 2023. Atomwise offers products and services including AI Discovery Engine and Pipeline Assets. Atomwise operates in a competitive market with competitors including Relay Therapeutics, Genesis Therapeutics, Unnatural Products, neoX Biotech and BioSymetrics, among others.
- Headquarter San Francisco, United States
- Employees 70 as on 31 Dec, 2023
- Founders Izhar Wallach
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Atomwise Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$218.64 M (USD)
in 8 rounds
-
Latest Funding Round
$44.28 M (USD), Series B
Mar 08, 2024
-
Investors
Tencent
& 17 more
-
Employee Count
70
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Atomwise
Atomwise offers a comprehensive portfolio of products and services, including AI Discovery Engine and Pipeline Assets. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses AI to identify new small molecule medicines for development
Facilitates co-developed drug pipelines and partnerships
Unlock access to complete
Unlock access to complete
Funding Insights of Atomwise
Atomwise has successfully raised a total of $218.64M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $44.28 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series B — $44.3M
-
First Round
First Round
(01 Jan 2013)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series B - Atomwise | Valuation |
investors |
|
| Oct, 2020 | Amount | Grant - Atomwise | Valuation |
investors |
|
| Aug, 2020 | Amount | Series B - Atomwise | Valuation | Sanabil , B Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Atomwise
Atomwise has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Tencent, Baidu and Khosla Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and funds of funds focused on early to mature stage companies and multiple funds
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Atomwise
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Atomwise
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atomwise Comparisons
Competitors of Atomwise
Atomwise operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Relay Therapeutics, Genesis Therapeutics, Unnatural Products, neoX Biotech and BioSymetrics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery platform is developed to study protein motion.
|
|
| domain | founded_year | HQ Location |
Computational platform for AI-driven small molecule drug discovery is developed.
|
|
| domain | founded_year | HQ Location |
Peptides are engineered via computational biology for undruggable targets.
|
|
| domain | founded_year | HQ Location |
Protein-protein interactions are researched and characterized to aid drug discovery.
|
|
| domain | founded_year | HQ Location |
Provider of a cognitive computing-based biomedical intelligence platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Atomwise
Frequently Asked Questions about Atomwise
When was Atomwise founded?
Atomwise was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Atomwise located?
Atomwise is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Atomwise a funded company?
Atomwise is a funded company, having raised a total of $218.64M across 8 funding rounds to date. The company's 1st funding round was a Series B of $123.01M, raised on Jan 01, 2013.
How many employees does Atomwise have?
As of Dec 31, 2023, the latest employee count at Atomwise is 70.
What does Atomwise do?
Atomwise was founded in 2012 in San Francisco, United States, within the biotechnology sector focused on AI applications. A platform for structure-based drug discovery is offered, leveraging proprietary AtomNet technology. Machine learning is employed by this technology to develop and identify small-molecule drugs according to their structural properties. Operations center on enabling efficient drug candidate screening and optimization for pharmaceutical research.
Who are the top competitors of Atomwise?
Atomwise's top competitors include Genesis Therapeutics, Unnatural Products and Relay Therapeutics.
What products or services does Atomwise offer?
Atomwise offers AI Discovery Engine and Pipeline Assets.
Who are Atomwise's investors?
Atomwise has 18 investors. Key investors include Tencent, Baidu, Khosla Ventures, Monsanto, and Gates Foundation.